U.S. markets closed
  • S&P 500

    4,228.48
    -55.26 (-1.29%)
     
  • Dow 30

    33,706.74
    -292.30 (-0.86%)
     
  • Nasdaq

    12,705.21
    -260.13 (-2.01%)
     
  • Russell 2000

    1,957.35
    -43.38 (-2.17%)
     
  • Crude Oil

    89.91
    -0.59 (-0.65%)
     
  • Gold

    1,760.30
    -10.90 (-0.62%)
     
  • Silver

    18.97
    -0.50 (-2.56%)
     
  • EUR/USD

    1.0039
    -0.0053 (-0.52%)
     
  • 10-Yr Bond

    2.9890
    +0.1090 (+3.78%)
     
  • GBP/USD

    1.1823
    -0.0109 (-0.92%)
     
  • USD/JPY

    136.9300
    +1.0680 (+0.79%)
     
  • BTC-USD

    21,189.43
    -1,614.93 (-7.08%)
     
  • CMC Crypto 200

    504.88
    -36.72 (-6.78%)
     
  • FTSE 100

    7,550.37
    +8.52 (+0.11%)
     
  • Nikkei 225

    28,930.33
    -11.81 (-0.04%)
     

New Strong Sell Stocks for March 25th

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
Investors need to pay close attention to Kala Pharmaceuticals (KALA) stock based on the movements in the options market lately.
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

21Vianet Group, Inc. VNET is a provider of carrier-neutral Internet data center services. The Zacks Consensus Estimate for its current year earnings has been revised 100% downward over the last 30 days.

Aegion Corporation AEGN is a provider of technology used in the maintenance, rehabilitation and strengthening of infrastructure. The Zacks Consensus Estimate for its current year earnings has been revised 10.2% downward over the last 30 days.

Champions Oncology, Inc. CSBR is a developer of technology solutions used in personalizing the development and use of oncology drugs. The Zacks Consensus Estimate for its current year earnings has been revised 8.3% downward over the last 30 days.

Concert Pharmaceuticals, Inc. CNCE is the owner and operator of a clinical stage biopharmaceutical company. The Zacks Consensus Estimate for its current year earnings has been revised 15.3% downward over the last 30 days.

Cross Country Healthcare, Inc. CCRN is a provider of healthcare staffing, recruiting and workforce solutions. The Zacks Consensus Estimate for its current year earnings has been revised 66.7% downward over the last 30 days.

View the entire Zacks Rank #5 List.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
21Vianet Group, Inc. (VNET) : Free Stock Analysis Report
 
Aegion Corporation (AEGN) : Free Stock Analysis Report
 
Concert Pharmaceuticals, Inc. (CNCE) : Free Stock Analysis Report
 
Champions Oncology, Inc. (CSBR) : Free Stock Analysis Report
 
Cross Country Healthcare, Inc. (CCRN) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research